Dhanuka Agritech Ltd
Dhanuka Agritech Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
FY '26 top line growth expected around 15% excluding Bayer molecules; additional revenue from Bayer products will add to this (Page 17). Top-line growth for FY '26 is expected around 15%, excluding revenue from Bayer molecules, which will add incremental growth.
From Dhanuka Agritech Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- FY '26 top line growth expected around 15% excluding Bayer molecules; additional revenue from Bayer products will add to this (Page 17).
- Volume growth for FY '26 is expected to be largely in line with top line growth, i.e., around 15% (Page 17).
- Bayer product revenues projected to grow at 15% year-on-year for the first 5 years starting FY '27 (Page 9).
- Specialty products and new product launches expected to drive volume growth, while generic products show no significant value growth but slight volume increase (Page 12, 16).
- New registrations and marketing efforts are planned to revive and grow acquired Bayer products by 10-15% CAGR in subsequent years (Page 14).
2 more points from Dhanuka Agritech Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Dhanuka Agritech Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No fresh CAPEX planned for Dahej plant currently due to low commercial viability of new products.
- Focus on product development in R&D for new products over the next 2-3 years.
- Intend to launch around 8 new products over the next 2 years, including rice herbicide and fungicide for grapes and horticultural crops in FY '26.
- One molecule manufacturing shift planned to India, expected to take around 1.5 to 2 years for regulatory approvals; another product manufacturing will remain outsourced.
- No fresh CAPEX at Dahej justified currently; efforts are on product development without major investments.
2 more points from Dhanuka Agritech Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Dhanuka Agritech Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly mention the current or expected order book or pending orders for Dhanuka Agritech Limited.
- However, it is indicated that the company expects to generate revenue from Bayer-acquired products, with full transition to Dhanuka's books by FY '27.
- For FY '26, revenue from these products is expected in the range of INR 60-70 crores.
- The company plans around 8 new product launches over the next 2 years to support growth.
- Domestic formulation business is growing, driven largely by specialty products, with volume growth expected around 15% excluding Bayer molecules.
2 more points from Dhanuka Agritech Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Dhanuka Agritech Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹483 Cr, net profit ₹98 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Dhanuka Agritech Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Fertilizers & Agrochemicals this season
- Sumitomo Chemical India Ltd (Q3 FY25)
641.9 crore, up 18% YoY from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- Punjab Chemicals & Crop Protection Ltd (Q3 FY25)
Capacity utilization for agrochemical division is at 72%, performance chemicals at 52%, with expansion plans underway, supporting growth (Page 3). Key concall…
- Paradeep Phosphates Ltd (Q3 FY25)
Q3 FY25 sales surged 47% YoY to 870,586 metric tons; 9 months sales up 13% YoY to 2.29 million tons. Key concall takeaways from Paradeep Phosphates Ltd's Q3…
- Coromandel International Ltd (Q3 FY25)
550-600 crores to about Rs. Key concall takeaways from Coromandel International Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Dhanuka Agritech Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Dhanuka Agritech Ltd Q3 FY25 results?
FY '26 top line growth expected around 15% excluding Bayer molecules; additional revenue from Bayer products will add to this (Page 17). Top-line growth for FY '26 is expected around 15%, excluding revenue from Bayer molecules, which will add incremental growth.
What is Dhanuka Agritech Ltd share price analysis?
Dhanuka Agritech Ltd currently shows a neutral. The stock trades at a P/E of 16.7 with a market cap of ₹4,482 Cr. Investors should review the full earnings analysis for detailed insights.
Is Dhanuka Agritech Ltd planning capital expenditure?
No fresh CAPEX planned for Dahej plant currently due to low commercial viability of new products.
Keep Dhanuka Agritech Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.